Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma

NCT01667289 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped unexpected high grade of mucositis observed

Conditions

Extranodal NK/T-cell Lymphoma, Nasal Type

Interventions

RADIATION: Radiotherapy alone
DRUG: Concurrent chemoradiation

Sponsor

Fudan University